Skip to content

Clinical trials

Phase 4 Bronchiolitis Obliterans Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Phase: Phase 4 Country / region: United States Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20061
20071
20083
20102
20142
20151
20162
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Watson Pharmaceuticals2
Amgen1
Apkar Apkarian1
Columbia University1
JHSPH Center for Clinical Trials1
National Institute of Mental Health (NIMH)1
Nevro Corp1
Northwestern University1
Pfizer1
Rush University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome18
Pain3
Anemia2
Anemia, Iron-Deficiency2
Dermatitis2
Iron Deficiencies2
Kidney Failure, Chronic2
Renal Insufficiency2
Renal Insufficiency, Chronic2
Asthma1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.